{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:41:01Z","timestamp":1778121661798,"version":"3.51.4"},"reference-count":44,"publisher":"American Diabetes Association","issue":"6","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,6,1]]},"abstract":"<jats:p>OBJECTIVE\u2014To assess current and long-term associations of glycemia with microalbuminuria, a marker of generalized endothelial injury.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014We measured clinical characteristics, fasting plasma glucose, and the urinary albumin-to-creatinine ratio (UACR) in 1,311 men and 1,518 women attending the sixth examination cycle (1995\u20131998) of the Framingham Offspring Study. After excluding participants with diabetes or cardiovascular disease (CVD) at the baseline examination (1971\u20131974), we used fasting glucose measured at baseline, examination 6, and at least two additional examinations from 1974 to 1995 in regression models to predict risk for microalbuminuria (UACR \u226530 mg\/g) associated with baseline, current, and 24-year time-integrated glycemia.<\/jats:p>\n               <jats:p>RESULTS\u2014Microalbuminuria was present in 9.5% of men and 13.4% of women. Among men, age-adjusted odds ratios (95% CI) for microalbuminuria associated with each 0.28 mmol\/l (5 mg\/dl) increase in baseline, current, and time-integrated glucose levels were 1.12 (1.00\u20131.16), 1.08 (1.05\u20131.10), and 1.16 (1.11\u20131.21), respectively. These effects persisted after adjustment for systolic blood pressure and other confounders. Higher glucose levels also predicted incident diabetes and CVD. Mean time-integrated glucose levels were highest among men who developed both CVD and microalbuminuria (SE 6.82 \u00b1 0.16 mmol\/l), intermediate among men with either condition (6.03 \u00b1 0.65 mmol\/l), and lowest among men with neither condition (5.49 \u00b1 0.02 mmol\/l; P &amp;lt; 0.001 for all pairwise comparisons). We observed similar associations in women.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014Long-term hyperglycemia and subdiabetic glycemia increase risk for microalbuminuria. Microalbuminuria, type 2 diabetes, and CVD seem to arise together over the course of decades, consistent with the hypothesis that they share a common antecedent.<\/jats:p>","DOI":"10.2337\/diacare.25.6.977","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T22:51:27Z","timestamp":1173135087000},"page":"977-983","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":70,"title":["Longitudinal Association of Glycemia and Microalbuminuria"],"prefix":"10.2337","volume":"25","author":[{"given":"James B.","family":"Meigs","sequence":"first","affiliation":[{"name":"General Medicine Division and Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Sr.","given":"Ralph B.","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"Department of Mathematics, Statistics, and Consulting Unit, Boston University, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Nathan","sequence":"additional","affiliation":[{"name":"Diabetes Unit and Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Rifai","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Medical Center and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.F.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Framingham Heart Study, Boston University School of Medicine, Framingham, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031214122487700_R1","doi-asserted-by":"crossref","unstructured":"Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med\u2008310:356\u2013360, 1984","DOI":"10.1056\/NEJM198402093100605"},{"key":"2022031214122487700_R2","doi-asserted-by":"crossref","unstructured":"Valmadrid CT, Klein R, Moss SE, Klein BEK: The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med\u2008160:1093\u20131100, 2000","DOI":"10.1001\/archinte.160.8.1093"},{"key":"2022031214122487700_R3","doi-asserted-by":"crossref","unstructured":"Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet\u20082:530\u2013533, 1988","DOI":"10.1016\/S0140-6736(88)92657-8"},{"key":"2022031214122487700_R4","doi-asserted-by":"crossref","unstructured":"Mogensen CE: Urinary albumin excretion in early and long-term juvenile diabetes. Scand J Clin Lab Invest\u200828:183\u2013193, 1971","DOI":"10.3109\/00365517109086899"},{"key":"2022031214122487700_R5","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study Group: UK Prospective Diabetes Study (UKPDS) X: urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycemia, and hypertriglyceridemia. Diabetologia\u200836:1021\u20131029, 1993","DOI":"10.1007\/BF02374494"},{"key":"2022031214122487700_R6","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group: The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes\u200845:1289\u20131298, 1996","DOI":"10.2337\/diab.45.10.1289"},{"key":"2022031214122487700_R7","doi-asserted-by":"crossref","unstructured":"Klein R, Klein BEK, Moss SE: Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care\u200816:1325\u20131330, 1993","DOI":"10.2337\/diacare.16.10.1325"},{"key":"2022031214122487700_R8","doi-asserted-by":"crossref","unstructured":"Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC: Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia\u200832:870\u2013876, 1989","DOI":"10.1007\/BF00297452"},{"key":"2022031214122487700_R9","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med\u2008329:977\u2013986, 1993","DOI":"10.1056\/NEJM199309303291401"},{"key":"2022031214122487700_R10","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet\u2008352:837\u2013853, 1998","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"2022031214122487700_R11","doi-asserted-by":"crossref","unstructured":"Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia\u200832:219\u2013226, 1989","DOI":"10.1007\/BF00285287"},{"key":"2022031214122487700_R12","doi-asserted-by":"crossref","unstructured":"Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS: Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes\u200846(Suppl. 2):S9\u2013S13, 1997","DOI":"10.2337\/diab.46.2.S9"},{"key":"2022031214122487700_R13","doi-asserted-by":"crossref","unstructured":"Stern MP: Diabetes and cardiovascular disease: the \u201ccommon soil\u201d hypothesis. Diabetes\u200844:369\u2013374, 1995","DOI":"10.2337\/diabetes.44.4.369"},{"key":"2022031214122487700_R14","doi-asserted-by":"crossref","unstructured":"Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA\u2008241:2035\u20132038, 1979","DOI":"10.1001\/jama.241.19.2035"},{"key":"2022031214122487700_R15","doi-asserted-by":"crossref","unstructured":"Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of diabetes? JAMA\u2008263:2893\u20132898, 1990","DOI":"10.1001\/jama.263.21.2893"},{"key":"2022031214122487700_R16","doi-asserted-by":"crossref","unstructured":"Haffner SM, Gonzales C, Valdez RA, Mykkanen L, Hazuda HP, Mitchell BD, Monterrosa A, Stern MP: Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia\u200836:1002\u20131006, 1993","DOI":"10.1007\/BF02374491"},{"key":"2022031214122487700_R17","doi-asserted-by":"crossref","unstructured":"Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M: Microalbuminuria precedes the development of NIDDM. Diabetes\u200843:552\u2013557, 1994","DOI":"10.2337\/diabetes.43.4.552"},{"key":"2022031214122487700_R18","doi-asserted-by":"crossref","unstructured":"Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM: Microalbuminuria is associated with insulin resistance in nondiabetic subjects. Diabetes\u200847:793\u2013800, 1998","DOI":"10.2337\/diabetes.47.5.793"},{"key":"2022031214122487700_R19","doi-asserted-by":"crossref","unstructured":"Despres J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien P-J: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med\u2008334:952\u2013957, 1996","DOI":"10.1056\/NEJM199604113341504"},{"key":"2022031214122487700_R20","doi-asserted-by":"crossref","unstructured":"Mattock MB, Barnes DJ, Viberti GC, Keen H, Burt D, Hughes JM, Fitzgerald AP, Sandhu B, Jackson PG: Microalbuminuria and coronary heart disease in NIDDM: an incidence study. Diabetes\u200847:1786\u20131792, 1998","DOI":"10.2337\/diabetes.47.11.1786"},{"key":"2022031214122487700_R21","doi-asserted-by":"crossref","unstructured":"Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS: Urinary albumin excretion: an independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol\u200819:1992\u20131997, 1999","DOI":"10.1161\/01.ATV.19.8.1992"},{"key":"2022031214122487700_R22","doi-asserted-by":"crossref","unstructured":"Kannel WB, Feinleib M, McNamara JR, Garrison RJ, Castelli WP: An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol\u2008110:281\u2013290, 1979","DOI":"10.1093\/oxfordjournals.aje.a112813"},{"key":"2022031214122487700_R23","doi-asserted-by":"crossref","unstructured":"McNamara JR, Schaefer EJ: Automated enzymatic standardized lipid analyses for plasma and lipid lipoprotein fractions. Clin Chim Acta\u2008166:1\u20138, 1987","DOI":"10.1016\/0009-8981(87)90188-4"},{"key":"2022031214122487700_R24","unstructured":"Cupples LA, D\u2019Agostino RB: Section 34: some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study, 30-year followup. In The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Kannel W, Wolf P, Garrison R. Eds. Washington, DC, U.S. Department of Commerce, 1988"},{"key":"2022031214122487700_R25","doi-asserted-by":"crossref","unstructured":"Nathan DM, Rosenbaum C, Protasowicki VD: Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care\u200810:414\u2013418, 1987","DOI":"10.2337\/diacare.10.4.414"},{"key":"2022031214122487700_R26","doi-asserted-by":"crossref","unstructured":"Bakker AJ: Detection of microalbuminuria: receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care\u200822:307\u2013313, 1999","DOI":"10.2337\/diacare.22.2.307"},{"key":"2022031214122487700_R27","unstructured":"SAS Institute I: SAS\/STAT User\u2019s Guide. Version 6, 4th ed. Cary, NC, SAS Institute, 1989"},{"key":"2022031214122487700_R28","doi-asserted-by":"crossref","unstructured":"Tarsio JF, Reger LA, Furcht LT: Molecular mechanisms in basement membrane complications of diabetes: alterations in heparin, laminin, and type IV collagen association. Diabetes\u200837:532\u2013539, 1988","DOI":"10.2337\/diabetes.37.5.532"},{"key":"2022031214122487700_R29","doi-asserted-by":"crossref","unstructured":"Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD: Development and progression of renal disease in Pima Indians with non- insulin-dependent diabetes mellitus: Diabetic Renal Disease Study Group. N Engl J Med\u2008335:1636\u20131642, 1996","DOI":"10.1056\/NEJM199611283352203"},{"key":"2022031214122487700_R30","doi-asserted-by":"crossref","unstructured":"Fujita H, Narita T, Ito S: Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance. Diabetes Care\u200822:823\u2013826, 1999","DOI":"10.2337\/diacare.22.5.823"},{"key":"2022031214122487700_R31","doi-asserted-by":"crossref","unstructured":"Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O\u2019Fallon WM, Palumbo PJ: Chronic renal failure in non-insulin-dependent diabetes mellitus: a population-based study in Rochester, Minnesota. Ann Intern Med\u2008111:788\u2013796, 1989","DOI":"10.7326\/0003-4819-111-10-788"},{"key":"2022031214122487700_R32","doi-asserted-by":"crossref","unstructured":"Nelson RG, Knowler WC, Pettitt DJ, Hanson RL, Bennett PH: Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care\u200818:182\u2013187, 1995","DOI":"10.2337\/diacare.18.2.182"},{"key":"2022031214122487700_R33","doi-asserted-by":"crossref","unstructured":"Smulders YM, Rakic M, Stehouwer CD, Weijers RN, Slaats EH, Silberbusch J: Determinants of progression of microalbuminuria in patients with NIDDM: a prospective study. Diabetes Care\u200820:999\u20131005, 1997","DOI":"10.2337\/diacare.20.6.999"},{"key":"2022031214122487700_R34","doi-asserted-by":"crossref","unstructured":"Forsblom CM, Groop PH, Ekstrand A, Totterman KJ, Sane T, Saloranta C, Groop L: Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care\u200821:1932\u20131938, 1998","DOI":"10.2337\/diacare.21.11.1932"},{"key":"2022031214122487700_R35","doi-asserted-by":"crossref","unstructured":"Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R: Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med\u2008158:998\u20131004, 1998","DOI":"10.1001\/archinte.158.9.998"},{"key":"2022031214122487700_R36","doi-asserted-by":"crossref","unstructured":"Fogarty DG, Hanna LS, Wantman M, Warram JH, Krolewski AS, Rich SS: Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes\u200849:1057\u20131063, 2000","DOI":"10.2337\/diabetes.49.6.1057"},{"key":"2022031214122487700_R37","unstructured":"Gerstein HC, Mann JF, Pogue J, Dinneen SF, Halle JP, Hoogwerf B, Joyce C, Rashkow A, Young J, Zinman B, YusufS: Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study: the HOPE Study Investigators. Diabetes Care\u200823(Suppl. 2):B35\u2013B39, 2000"},{"key":"2022031214122487700_R38","doi-asserted-by":"crossref","unstructured":"Metcalf PA, Baker JR, Scragg RK, Dryson E, Scott AJ, Wild CJ: Microalbuminuria in a middle-aged workforce: effect of hyperglycemia and ethnicity. Diabetes Care\u200816:1485\u20131493, 1993","DOI":"10.2337\/diacare.16.11.1485"},{"key":"2022031214122487700_R39","doi-asserted-by":"crossref","unstructured":"Meigs JB, Nathan DM, Wilson PWF, Cupples LA, Singer DE: Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance: the Framingham Offspring Study. Ann Intern Med\u2008128:524\u2013533, 1998","DOI":"10.7326\/0003-4819-128-7-199804010-00002"},{"key":"2022031214122487700_R40","doi-asserted-by":"crossref","unstructured":"Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet\u2008340:319\u2013323, 1992","DOI":"10.1016\/0140-6736(92)91401-S"},{"key":"2022031214122487700_R41","doi-asserted-by":"crossref","unstructured":"Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A: Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes\u200848:1856\u20131862, 1999","DOI":"10.2337\/diabetes.48.9.1856"},{"key":"2022031214122487700_R42","doi-asserted-by":"crossref","unstructured":"Mitchell BD, Kammerer CM, Blangero J, Mahaney MC, Rainwater DL, Dyke B, Hixson JE, Henkel RD, Sharp RM, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW: Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans: the San Antonio Family Heart Study. Circulation\u200894:2159\u20132170, 1996","DOI":"10.1161\/01.CIR.94.9.2159"},{"key":"2022031214122487700_R43","doi-asserted-by":"crossref","unstructured":"Phillips DI: Insulin resistance as a programmed response to fetal undernutrition. Diabetologia\u200839:1119\u20131122, 1996","DOI":"10.1007\/BF00400663"},{"key":"2022031214122487700_R44","doi-asserted-by":"crossref","unstructured":"Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D: The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med\u2008133:176\u2013182, 2000","DOI":"10.7326\/0003-4819-133-3-200008010-00008"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/25\/6\/977\/589847\/dc0602000977.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/25\/6\/977\/589847\/dc0602000977.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T14:12:39Z","timestamp":1647094359000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/25\/6\/977\/21258\/Longitudinal-Association-of-Glycemia-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,1]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.25.6.977","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,1]]}}}